Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: An aggregated study. 21266505 Schonfeld SJ, Pfeiffer RM, Lacey JV, Berrington de González A, Doody MM, Greenlee RT, Park Y, Schairer C, Schatzkin A, Sigurdson AJ, Hartge P, Visvanathan K Am. J. Epidemiol. 2011 PLCO
Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. 20929901 Sigurdson AJ, Jones IM, Wei Q, Wu X, Spitz MR, Stram DA, Gross MD, Huang WY, Wang LE, Gu J, Thomas CB, Reding DJ, Hayes RB, Caporaso NE Carcinogenesis 2011 PLCO
Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. 21553078 Shikany JM, Flood AP, Kitahara CM, Hsing AW, Meyer TE, Willcox BJ, Redden DT, Ziegler RG Cancer Causes Control 2011 PLCO
Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. 21685357 Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC J. Natl. Cancer Inst. 2011 PLCO
Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial. 21764327 Hofmann JN, Yu K, Bagni RK, Lan Q, Rothman N, Purdue MP Cytokine 2011 PLCO
Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 21750727 Wentzensen N, Black A, Jacobs K, Yang HP, Berg CD, Caporaso N, Peters U, Ragard L, Buys SS, Chanock S, Hartge P PLoS ONE 2011 PLCO
Potential role of HE4 in multimodal screening for epithelial ovarian cancer. 21917606 Urban N, Thorpe JD, Bergan LA, Forrest RM, Kampani AV, Scholler N, O'Briant KC, Anderson GL, Cramer DW, Berg CD, McIntosh MW, Hartge P, Drescher CW J. Natl. Cancer Inst. 2011 PLCO
Building multi-marker algorithms for disease prediction-the role of correlations among markers. 21918599 Pinsky PF, Zhu CS Biomark Insights 2011 PLCO
A prospective evaluation of C-reactive protein levels and colorectal adenoma development. 21212059 Gunter MJ, Cross AJ, Huang WY, Stanczyk FZ, Purdue M, Xue X, Schoen R, Limburg PJ, Schatzkin A, Sinha R, Hayes RB Cancer Epidemiol. Biomarkers Prev. 2011 PLCO
The use of imputed values in the meta-analysis of genome-wide association studies. 21769935 Jiao S, Hsu L, Hutter CM, Peters U Genet. Epidemiol. 2011 PLCO
The landscape of recombination in African Americans. 21775986 Hinch AG, Tandon A, Patterson N, Song Y, Rohland N, Palmer CD, Chen GK, Wang K, Buxbaum SG, Akylbekova EL, Aldrich MC, Ambrosone CB, Amos C, Bandera EV, Berndt SI, Bernstein L, Blot WJ, Bock CH, Boerwinkle E, Cai Q, Caporaso N, Casey G, Cupples LA, … Nature 2011 PLCO
A special program to increase the participation of Hispanics in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Tenorio SL, Gamito EJ, Ogden S, Quintela J, Ordonez E, Crawford ED, Lamerato L Hisp Health Care Int 2011 PLCO
Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. 21715603 Chaturvedi AK, Kemp TJ, Pfeiffer RM, Biancotto A, Williams M, Munuo S, Purdue MP, Hsing AW, Pinto L, McCoy JP, Hildesheim A Cancer Epidemiol. Biomarkers Prev. 2011 PLCO
Evaluation of polygenic risk scores for predicting breast and prostate cancer risk. 21618606 Machiela MJ, Chen CY, Chen C, Chanock SJ, Hunter DJ, Kraft P Genet. Epidemiol. 2011 PLCO
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. 21465221 Kote-Jarai Z, Amin Al Olama A, Leongamornlert D, Tymrakiewicz M, Saunders E, Guy M, Giles GG, Severi G, Southey M, Hopper JL, Sit KC, Harris JM, Batra J, Spurdle AB, Clements JA, Hamdy F, Neal D, Donovan J, Muir K, Pharoah PD, Chanock SJ, Brown N, B… Hum. Genet. 2011 PLCO
Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. 21372204 Ciampa J, Yeager M, Amundadottir L, Jacobs K, Kraft P, Chung C, Wacholder S, Yu K, Wheeler W, Thun MJ, Divers WR, Gapstur S, Albanes D, Virtamo J, Weinstein S, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Hunter D, Hoover R, Tho… Cancer Res. 2011 PLCO
Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. 21637779 Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Chanock SJ, Kolb S, Signorello LB, Yamamura Y, Neslund-Dudas C, Thun MJ, Murphy A, Casey G, Sheng X, Wan P, Pooler LC, M… PLoS Genet. 2011 PLCO
Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. 21343373 Ahn J, Kibel AS, Park JY, Rebbeck TR, Rennert H, Stanford JL, Ostrander EA, Chanock S, Wang MH, Mittal RD, Isaacs WB, Platz EA, Hayes RB Clin. Cancer Res. 2011 PLCO
Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions. 22086326 Ciampa J, Yeager M, Jacobs K, Thun MJ, Gapstur S, Albanes D, Virtamo J, Weinstein SJ, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Hunter D, Hoover R, Thomas G, Chanock S, Holmes C, Chatterjee N Hum. Hered. 2011 PLCO
Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. 21531787 Chung CC, Ciampa J, Yeager M, Jacobs KB, Berndt SI, Hayes RB, Gonzalez-Bosquet J, Kraft P, Wacholder S, Orr N, Yu K, Hutchinson A, Boland J, Chen Q, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-Tassin G, … Hum. Mol. Genet. 2011 PLCO